Meta-analysis of randomized controlled trials on androgens versus erythropoietin for anaemia of chronic kidney disease: Implications for developing countries

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Adamu, B ^a   Ma'aji, S M ^b   Erwin, P J ^c   Tleyjeh, I M ^d  

^a BAYERO UNIVERSITY   (Nigeria)

^b USMANU DANFODIYO UNIVERSITY   (Nigeria)

^c Mayo Clinic   (United States)

^d KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869034605     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/580437     Document Type: Article

References (22)

1. Clement F. M., Klarenbach S., Tonelli M., Wiebe N., Hemmelgarn B., Manns B. J., An economic evaluation of erythropoiesis-stimulating agents in CKD. American Journal of Kidney Diseases 2010 56 6 1050 1061 2-s2.0-78649420110 10.1053/j.ajkd.2010.07.015
2. Maïz H. B., Abderrahim E., Zouaghi K., Anemia and end-stage renal disease in the developing world. Artificial Organs 2002 26 9 760 764 2-s2.0-0036042704 10.1046/j.1525-1594.2002.07066.x (Pubitemid 35013759)
3. Cattran D. C., Fenton S. S. A., Wilson D. R., A controlled trial of nandrolone decanoate in the treatment of uremic anemia. Kidney International 1977 12 6 430 437 2-s2.0-0017620950 (Pubitemid 8294733)
4. Navarro J. F., Mora C., Macía M., García J., Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney International 2002 61 4 1537 1544 2-s2.0-0036227448 10.1046/j.1523-1755. 2002.00271.x (Pubitemid 34304516)
5. Gascon A., Belvis J. J., Berisa F., Iglesias E., Estopinan V., Teruel J. L., Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. Geriatric Nephrology and Urology 1999 9 2 67 72 2-s2.0-0032837614 10.1023/A:1008306301255 (Pubitemid 29438143)
6. Aggarwal H. K., Sehgal R., Singh S., Nand N., Bharti K., Chakrabarti D., Evaluation of efficacy of low dose recombinant human erythropoietin in combination with androgen therapy in anaemia of chronic renal failure. Journal, Indian Academy of Clinical Medicine 2005 6 3 208 215 2-s2.0-27844537510 (Pubitemid 41657807)
7. Singh N. P., Ganguli A., Singh T., A comparative study of nandrolone decanoate versus recombinant human erythropoietin on anemia in Indian pre-dialysis chronic kidney disease patients. Nephrology Dialysis Transplantation 2003 18 supplement 4 692 693
8. Levin A., Prevalence of cardiovascular damage in early renal disease. Nephrology Dialysis Transplantation 2001 16 2 7 11 2-s2.0-0035014350 (Pubitemid 32479547)
9. Locatelli F., Pisoni R. L., Akizawa T., Cruz J. M., Deoreo P. B., Lameire N. H., Held P. J., Anemia management for hemodialysis patients: kidney disease outcomes quality initiative (K/DOQI) guidelines and dialysis outcomes and practice patterns study (DOPPS) findings. American Journal of Kidney Diseases 2004 44 5, supplement 2 S27 S33 2-s2.0-5644295619 10.1053/j.ajkd.2004.08.008 (Pubitemid 39369938)
10. Unger E. F., Thompson A. M., Blank M. J., Temple R., Erythropoiesis- stimulating agents-time for a reevaluation. New England Journal of Medicine 2010 362 3 189 192 2-s2.0-74849088872 10.1056/NEJMp0912328
11. Gordon A. S., Zanjani E. D., Levere R. D., Kappas A., Stimulation of mammalian erythropoiesis by 5beta-H steroid metabolites. Proceedings of the National Academy of Sciences of the United States of America 1970 65 4 919 924 2-s2.0-0014768323
12. Johnson C. A., Use of androgens in patients with renal failure. Seminars in Dialysis 2000 13 1 36 39 2-s2.0-0033631032
13. Solomon L. R., Hendler E. D., Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics. Acta Haematologica 1988 79 1 12 19 2-s2.0-0023851895 (Pubitemid 18054349)
14. Higgins J. P. T., Green S., Recommendations on testing for funnel plot asymmetry. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 2011 Queensland, Australia The Cochrane Collaboration
15. Lau J., Ioannidis J. P. A., Terrin N., Schmid C. H., Olkin I., The case of the misleading funnel plot. British Medical Journal 2006 333 7568 597 600 2-s2.0-33748935095 (Pubitemid 44433638)
16. Teruel J. L., Marcen R., Navarro-Antolin J., Aguilera A., Fernandez-Juarez G., Ortuño J., Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study. Journal of the American Society of Nephrology 1996 7 1 140 144 2-s2.0-0030060615 (Pubitemid 26068450)
17. Paul A. K., Latif Z. A., Iqbal S., Amin F., Shefin S. M., Ashrafuzzaman S. M., Androgen versus erythropoietin for the treatment of anaemia of pre-dialysis chronic kidney disease. Mymensingh Medical Journal 2012 21 1 125 128
18. Eiam-Ong S., Buranaosot S., Eiam-Ong S., Wathanavaha A., Pansin P., Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease. Journal of Renal Nutrition 2007 17 3 173 178 2-s2.0-34247216768 10.1053/j.jrn.2007.01.001 (Pubitemid 46617296)
19. Lee M. S., Ahn S. H., Song J. H., Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin. Korean Journal of Internal Medicine 2002 17 3 167 173 2-s2.0-0036728757
20. Gaughan W. J., Liss K. A., Dunn S. R., Mangold A. M., Buhsmer J. P., Michael B., Burke J. F., A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. American Journal of Kidney Diseases 1997 30 4 495 500 2-s2.0-0030843550 (Pubitemid 27422295)
21. Sánchez de la Nieta M. D., Caparrós G., Rivera F., Epoetin-induced pure red cell aplasia successfully treated with androgens. Journal of Nephrology 2006 19 2 220 221 2-s2.0-33748855159 (Pubitemid 44420116)
22. Tang X., Gu R., Xie X. S., Wu T., Androgens for the anaemia of chronic kidney disease in adults (Protocol). Cochrane Database of Systematic Reviews. In press 2-s2.0-44949089620 10.1002/14651858.CD006881